Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

Last updated: July 28, 2022
Sponsor: Galderma R&D
Overall Status: Completed

Phase

3

Condition

Skin Aging

Treatment

N/A

Clinical Study ID

NCT00647556
US10067
  • Ages > 40
  • All Genders

Study Summary

The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or Female aged 40 years of age and older with Fitzpatrick skin types I throughIII
  • Clinically moderate to severe photodamage

Exclusion

Exclusion Criteria:

  • Subjects with history of laser resurfacing, dermabrasion, medium or deep chemical peelof the face
  • Subjects with diagnosis of skin cancer within 3 months of study entry
  • Subjects who have had superficial chemical peels, exfoliation or microdermabrasion ofthe face within 3 months of study entry
  • Subjects who have had botulinum toxin for facial rejuvenation within 6 months of studyentry and are unwilling to refrain from botulinum toxin treatments during the study

Study Design

Total Participants: 30
Study Start date:
April 01, 2008
Estimated Completion Date:
January 31, 2010

Study Description

Same as above.

Connect with a study center

  • University of Michigan Department of Dermatology

    Ann Arbor, Michigan 48109
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.